10x Genomics, Inc. (TXG)
$71.79-4.52%Close
SELLCRISIS · day 6
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $9.1B
- Beta
- 1.99
- P/E (TTM)
- -121.68
- Short % float
- 13.39%
- Days to cover
- 4.5
- SI change
- -7.9%
- 1W
- -11.00%
- 1M
- +2.40%
- vs SPY 1W
- -10.86%
- vs SPY 1M
- -0.11%
Industry peers
FMP comparable companies · ranked by market cap
- ABUYAgilent Technologies, Inc.$48.2BBULLQ 16$170.54+0.16%
- ILMNBUYIllumina, Inc.$42.1BBULLQ 16$278.17-1.98%
- RVTYBUYRevvity, Inc.$17.2BBULLQ 12$154.18-0.34%
- GNNSFGenscript Biotech Corporation$11.4B$5.20
- TECHBUYBio-Techne Corporation$11.3BBULLQ 19$72.46-0.11%
- TWSTSELLTwist Bioscience Corporation$9.9BCRISISQ 30$159.78-0.35%
- BIOSELLBio-Rad Laboratories, Inc.$9.9BBEARQ 19$366.16-0.19%
- QGENBUYQiagen N.V.$9.4BRECOVERYQ 16$45.38+0.29%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on TXG?
- LOPJLB’s latest quantitative signal on 10x Genomics, Inc. (TXG) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is TXG in?
- 10x Genomics, Inc. (TXG) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does 10x Genomics, Inc. (TXG) do?
- Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent life science technology company. The firm specializes in creating and distributing sophisticated instrumentation, essential consumables, and software designed for in-depth analysis of biological systems. Its market presence extends globally, coveri…